Hepatitis C 
The MD Magazine Hepatitis C condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Restricted Reimbursement for DAAs Hinders Progress Towards Global Hepatitis C Eradication Goal
Although DAAs achieve sustained virologic response rates above 90%, they are expensive in both Canada and the US. A recent Canadian study examined the limitations hepatitis C patients there face in receiving reimbursement for their treatment.
An interesting discovery about some Irish women exposed to the hepatitis C virus in the late 1970s has led scientists to study the possible existence of a super immune gene.
Measuring the hepatitis C virus (HCV) antigen in patients who are receiving protease inhibitors (PI) could provide an alternative to monitoring treatment response, according to a recent study.
Though testing patients in the emergency department for hepatitis C adds time to their length of stay, the benefits of detection are self-evident.
Researchers at The Scripps Research Institute mapped a key protein in Hepatitis C to determine why so many previous attempts at a vaccine had fallen short.
Keeping patients coming back after they start hepatitis treatment requires interventions sometimes--but there are many low-tech tactics that work.
Though under lock and key, state prisoners are considered "hard to reach" when it comes to getting them into treatment for hepatitis C. A health Affairs study looked at how states vary in attitudes, practices, and spending.
German researchers need more data before they can decide whether the hepatitis drug combo sofosbuvir/velpatasvir (Epclusa/Gilead Sciences) is better than earlier antivirals for all genotypes of hepatitis C virus.
The risk of getting Non-Hodkins Lymphoma is greater in patients co-infected with hepatitis B and hepatitis C if those patients are also receiving anti-retroviral therapy for HIV infection.

Most Popular


$vacMongoViewPlus$ $vAR$